George A. Fisher Jr.
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Schedule appointmentGI Oncology Clinic 875 Blake Wilbur Dr Clinic B Stanford, CA 94305-5820 Tel Work (650) 498-6000 Fax (650) 725-9113
-
Academic Offices
Personal Information Tel (650) 725-9057Administrative Contact Diane Ayala Administrative Assistant Email Tel Work 650-725-9057Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > GI Oncology
- Colorectal Cancer
- Colorectal Cancer - Medical Oncology
- Gastrointestinal Cancers
- Gastrointestinal Cancers - Medical Oncology
Administrative Appointments
- Director, Cancer Clinical Trials Office (2004 - present)
Education & Community
Professional Education
- Fellowship: Stanford University Medical Center, CA (1993)
- Residency: Stanford University Medical Center, CA (1989)
- Internship: Stanford University Medical Center, CA (1988)
- Medical Education: Stanford University School of Medicine, CA (1987)
- BS, Stanford University, Biology (1976)
Scientific Focus
Research Interests
The research program focuses on clinical trials involving new investigational agents for the treatment of a wide range of cancers. Active clinical trials include studies involving doxorubicin and taxol and agents that reverse resistance to these drugs, such as PSC 833.
Other interests include phase I and II studies using anti-sense DNA, targeting PKC-alpha in ovarian cancer and the role of gene-modified autologous T cells engineered to recognize the TAG-72 antigen on colon cancer cells.
Publications
- Phase II study of imatinib in unresectable hepatocellular carcinoma. "Am J Clin Oncol" 2008 ; 1 84-8
- Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. "Int J Radiat Oncol Biol Phys" 2008 ; 3 678-86
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate. "Ann Oncol" 2008 ; 9 1613-8
- A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer. "Clin Cancer Res" 2008 ; 21 7074-9
- Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer. "Expert Opin Investig Drugs" 2007 ; 4 467-76
